Furthermore, the pharmacologic inhibition of PKM2 by shikonin or compound 3K attenuated microglial activation and the microglia-specific ablation of PKM2 disrupted the glycolysis/H4K12la/PKM2-positive feedback loop and improved spatial learning and memory in AD mice [72]. Here, PKM is linked to Alzheimer disease.